Источники о нейролептиках
Волков В.П. Кардиотоксичность фенотиазиновых нейролептиков (обзор литературы) // Психиатрия и психофармакотерапия. — 2010. — № 2.
Дробижев М.Ю., Добровольский А.В., Долецкий А.А. Кардиологические и психопатологические аспекты безопасности комбинированной кардио- и психотропной терапии // Психиатрия и психофармакотерапия. — 2005. — Т. 7, № 3.
Мосолов С.Н., Рывкин П.В., Сердитов О.В., Ладыженский М.Я., Потапов А.В. Метаболические побочные эффекты современной антипсихотической фармакотерапии // Социальная и клиническая психиатрия. — Москва, 2008. — Т. 18, вып. 3. — С. 75—90.
http://www.ncbi.nlm.nih.gov/pubmed/16696579 (Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia)
http://www.ncbi.nlm.nih.gov/pubmed/17927296 (Adverse effects of atypical antipsychotics : differential risk and clinical implications)
http://www.ncbi.nlm.nih.gov/pubmed/17235331 (Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study)
http://www.ncbi.nlm.nih.gov/pubmed/20091600?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=11 (Quetiapine versus other atypical antipsychotics for schizophrenia)
http://www.ncbi.nlm.nih.gov/pubmed/20091599?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=12 (Amisulpride versus other atypical antipsychotics for schizophrenia)
http://www.ncbi.nlm.nih.gov/pubmed/20066804?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=39 (Metabolic side effects of second generation antipsychotics in drug-naïve patients: a preliminary study)
http://www.ncbi.nlm.nih.gov/pubmed/20041330?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=79 (Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions)
http://www.ncbi.nlm.nih.gov/pubmed/19700142?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=64 (Diabetes and second-generation (atypical) antipsychotics)
http://www.ncbi.nlm.nih.gov/pubmed/19643718?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=81 (Neurobiological and pharmacologic aspects of atypical antipsychotic drugs)
http://www.ncbi.nlm.nih.gov/pubmed/19552487?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=108 (Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms)
http://www.ncbi.nlm.nih.gov/pubmed/19506725?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=127 (Role of the central cholinergic system in the therapeutics of schizophrenia)
http://www.ncbi.nlm.nih.gov/pubmed/19389335?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=158 (Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison)
http://www.ncbi.nlm.nih.gov/pubmed/19164494?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=220
(Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder)
http://www.ncbi.nlm.nih.gov/pubmed/16785265
(The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics)
http://archpsyc.ama-assn.org/cgi/content/full/58/12/1161 http://content.nejm.org/cgi/content/full/360/3/225
(Antipsychotics and the Risk of Sudden Cardiac Death)
https://www.ncbi.nlm.nih.gov/pubmed/24455199
(Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database)
http://ww1.cpa-apc.org:8080/publications/archives/CJP/2004/may/awad.asp
(New Antipsychotics, Compliance, Quality of Life, and Subjective Tolerability—Are Patients Better Off)
http://archpsyc.ama-assn.org/cgi/reprint/63/10/1079
(Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia)
http://www.ncbi.nlm.nih.gov/pubmed/11271726
(Abuse of neuroleptic drug by psychiatric patients)
http://pb.rcpsych.org/content/25/5/179.full
(High dose neuroleptics — who gives them and why?)
Участница:V for Vendetta/Источники о нейролептиках.